Evidence map›Paper›PMID 26161871›Full record

SynthesisPloS one2015

Peripheral Endothelial (Dys)Function, Arterial Stiffness and Carotid Intima-Media Thickness in Patients after Kawasaki Disease: A Systematic Review and Meta-Analyses.

Sanne M Dietz, Carline E A Tacke, Barbara A Hutten, Taco W Kuijpers

Registry-linked trialOpen access · goldAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03750123 (Cardiovascular Status of Children 5 Years After Kawasaki Disease), which is not on this map. Cited by 19 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 2 pooled it
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03750123 completednot on this mapstarted 2019, after this paper: background citation

Cardiovascular Status of Children 5 Years After Kawasaki Disease

Typeobservational_patient_registrySponsorMedical University of WarsawRan2019 to 2023Enrolled61ConditionsVasculitis, Systemic, Kawasaki Disease
3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 2 syntheses or guidelines pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Long-term health outcomes in young adults after Kawasaki disease.International journal of cardiology. Heart & vasculature · 2022
    Article
  10. Article
  11. Article
  12. Article
  13. Kawasaki Disease: Pathology, Risks, and Management.Vascular health and risk management · 2022
    Review
  14. Article
  15. Review
  16. Review
  17. Dissecting Kawasaki disease: a state-of-the-art review.European journal of pediatrics · 2017
    Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Sanne M DietzDepartment of pediatric hematology, immunology and infectious diseases, Emma Children's Hospital, Academic Medical Center (AMC), Amsterdam, The Netherlands.
Carline E A TackeDepartment of pediatric hematology, immunology and infectious diseases, Emma Children's Hospital, Academic Medical Center (AMC), Amsterdam, The Netherlands.
Barbara A HuttenDepartment of Clinical Epidemiology, Biostatistics and Bioinformatics, AMC, Amsterdam, The Netherlands.
Taco W KuijpersDepartment of pediatric hematology, immunology and infectious diseases, Emma Children's Hospital, Academic Medical Center (AMC), Amsterdam, The Netherlands.
Emma Kinderziekenhuis · NLAcademic Medical Center · NLNetherlands Bioinformatics Centre · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundKawasaki disease (KD) is a systemic pediatric vasculitis. Its main complication is the development of coronary arterial aneurysms (CAA), causing an increased risk for ischemia and myocardial infarction. It is unclear whether KD patients, apart from the presence of CAA, have an increased cardiovascular disease (CVD) risk due to the previous systemic vasculitis. The aim of this study was to systematically review and meta-analyse the literature regarding surrogate markers for CVD risk in KD patients.

methodsMedline and Embase were searched for articles comparing endothelial dysfunction (flow-mediated dilation, nitroglycerin-mediated dilation and peripheral arterial tonometry), vascular stiffness (stiffness index, pulse wave velocity) and carotid intima-media thickness (cIMT) between patients and controls. Two investigators assessed the articles for eligibility and evaluated quality.

resultsThirty studies were included. For all outcomes, moderate to high heterogeneity between studies was found. Most studies reported a decreased flow-mediated dilation in the whole KD- and CAA-positive group compared to controls, while data on CAA-negative patients were conflicting. The stiffness index was increased in the majority of studies evaluating the whole KD- and CAA-positive group, but not in most studies on CAA-negative patients. Mean cIMT was neither significantly increased in the whole KD-group nor in the CAA-positive group nor in most studies studying CAA-negative patients. Studies measuring maximum cIMT were conflicting.

conclusionLiterature suggests that surrogate markers for CVD risk in KD patients are increased in CAA-positive but not in CAA-negative patients. This may indicate that CAA-positive patients should be monitored for CVD in later life. The results of this review have to be interpreted with care due to substantial heterogeneity between studies and methodological limitations, as well as the lack of long-term follow-up studies.

Indexed as

Carotid Intima-Media ThicknessVascular StiffnessCardiovascular DiseasesCoronary AneurysmEndothelium, VascularHumansMucocutaneous Lymph Node SyndromeRegression AnalysisRisk Factors

Identifiers

PMID26161871
PMCPMC4498761
OpenAlexW849402583

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.